J
Jiangsu Boxin Investing & Holdings Co Ltd
SSE:600083
Jiangsu Boxin Investing & Holdings Co Ltd
SSE:600083
Price:
0.92
CNY
Market Closed
Market Cap:
¥211.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
J
|
Jiangsu Boxin Investing & Holdings Co Ltd
SSE:600083
|
CN |
|
Befesa SA
XETRA:BFSA
|
LU |
|
L
|
Lionco Pharmaceutical Group Co Ltd
SSE:603669
|
CN |
|
Natura &Co Holding SA
OTC:NTCOY
|
BR |
|
Natures Sunshine Products Inc
NASDAQ:NATR
|
US |
Balance Sheet
Balance Sheet Decomposition
Jiangsu Boxin Investing & Holdings Co Ltd
Jiangsu Boxin Investing & Holdings Co Ltd
Balance Sheet Decomposition is not available for
Jiangsu Boxin Investing & Holdings Co Ltd
Jiangsu Boxin Investing & Holdings Co Ltd
Balance Sheet
Jiangsu Boxin Investing & Holdings Co Ltd
Jiangsu Boxin Investing & Holdings Co Ltd
Currency: CNY
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
93
|
12
|
31
|
42
|
39
|
3
|
327
|
198
|
68
|
17
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
198
|
68
|
17
|
|
| Cash Equivalents |
93
|
12
|
31
|
42
|
39
|
3
|
327
|
0
|
0
|
0
|
|
| Total Receivables |
45
|
44
|
39
|
39
|
118
|
85
|
77
|
150
|
199
|
273
|
|
| Accounts Receivables |
45
|
43
|
38
|
38
|
87
|
66
|
29
|
127
|
177
|
172
|
|
| Other Receivables |
0
|
0
|
1
|
1
|
31
|
19
|
48
|
23
|
22
|
100
|
|
| Inventory |
16
|
36
|
37
|
24
|
22
|
3
|
0
|
0
|
0
|
5
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
326
|
1
|
39
|
2
|
5
|
1
|
|
| Total Current Assets |
154
|
92
|
107
|
104
|
505
|
93
|
443
|
350
|
272
|
296
|
|
| PP&E Net |
10
|
9
|
16
|
1
|
1
|
0
|
41
|
634
|
752
|
523
|
|
| PP&E Gross |
10
|
9
|
16
|
1
|
1
|
0
|
41
|
634
|
752
|
523
|
|
| Accumulated Depreciation |
2
|
4
|
7
|
1
|
1
|
1
|
1
|
71
|
120
|
346
|
|
| Intangible Assets |
7
|
7
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
76
|
67
|
0
|
|
| Other Long-Term Assets |
11
|
12
|
1
|
1
|
20
|
26
|
0
|
6
|
9
|
32
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
76
|
67
|
0
|
|
| Total Assets |
181
N/A
|
118
-35%
|
130
+10%
|
106
-19%
|
526
+396%
|
119
-77%
|
483
+308%
|
1 066
+121%
|
1 099
+3%
|
851
-23%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
43
|
29
|
30
|
20
|
9
|
2
|
42
|
55
|
30
|
16
|
|
| Accrued Liabilities |
3
|
5
|
5
|
3
|
7
|
1
|
8
|
35
|
29
|
5
|
|
| Short-Term Debt |
0
|
0
|
0
|
2
|
162
|
0
|
409
|
414
|
340
|
342
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
31
|
95
|
66
|
|
| Other Current Liabilities |
88
|
22
|
26
|
17
|
335
|
116
|
14
|
106
|
69
|
47
|
|
| Total Current Liabilities |
134
|
56
|
60
|
41
|
514
|
119
|
473
|
641
|
564
|
475
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
56
|
123
|
93
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
5
|
2
|
|
| Minority Interest |
8
|
10
|
14
|
0
|
0
|
0
|
0
|
175
|
196
|
120
|
|
| Other Liabilities |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
169
|
128
|
173
|
|
| Total Liabilities |
143
N/A
|
66
-54%
|
75
+13%
|
42
-44%
|
514
+1 130%
|
119
-77%
|
473
+297%
|
1 044
+121%
|
1 015
-3%
|
862
-15%
|
|
| Equity | |||||||||||
| Common Stock |
230
|
230
|
230
|
230
|
230
|
230
|
230
|
230
|
230
|
230
|
|
| Retained Earnings |
288
|
275
|
272
|
262
|
314
|
327
|
316
|
303
|
241
|
365
|
|
| Additional Paid In Capital |
96
|
96
|
96
|
96
|
96
|
96
|
96
|
96
|
96
|
125
|
|
| Total Equity |
39
N/A
|
52
+34%
|
55
+6%
|
64
+17%
|
12
-81%
|
1
N/A
|
10
N/A
|
23
+123%
|
84
+274%
|
10
N/A
|
|
| Total Liabilities & Equity |
181
N/A
|
118
-35%
|
130
+10%
|
106
-19%
|
526
+396%
|
119
-77%
|
483
+308%
|
1 066
+121%
|
1 099
+3%
|
851
-23%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
230
|
230
|
230
|
230
|
230
|
230
|
230
|
230
|
230
|
230
|
|
Switch to:
Switch to:
See Also
Discover More
